V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014243 | 220014713 | 0 | 0 | Curative (C) | 2015-02-05 | 2015-02-05 | AML16 DA 3+10 | N | N | 220032991 | AML16 TRIAL |
| 220014244 | 220008778 | 1.8 | 8.5 | Not known (9) | null | 2018-01-16 | Cyclophosphamide+Fludara+TBI Allo | Y | N | 220032995 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014245 | 220008779 | 1.77 | 67.8 | Adjuvant (A) | 2014-08-09 | 2014-08-20 | CYCLOPHOSPHAMIDE | N | N | 220032996 | CYCLOPHOSPHAMIDE |
| 220014246 | 220014714 | 1.72 | 99.2 | Curative (C) | 2016-05-27 | 2016-07-13 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220032996 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014247 | 220008781 | 1.58 | 79.4 | Palliative (P) | 2016-04-03 | 2016-04-14 | BOSUTINIB | N | N | 220033003 | BOSUTINIB |
| 220014248 | 220008781 | 1.55 | 83.8 | Palliative (P) | 2017-10-05 | 2017-10-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 220033003 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014249 | 220008781 | 1.73 | 12.4 | Not known (9) | 2013-05-24 | 2013-05-26 | Triple / Double Intrathecal Therapy | N | N | 220033003 | TRIPLE INTRATHECAL |
| 220014250 | 220008782 | 1.5 | null | Curative (C) | null | 2014-02-02 | Cyclophosphamide TBI Allograft | null | null | 220033010 | CYCLOPHOSPHAMIDE |
| 220014251 | 220008785 | 1.69 | 0 | Adjuvant (A) | 2017-02-21 | 2017-02-21 | AML16 DA 3+8 | N | N | 220033011 | AML16 TRIAL |
| 220014252 | 220008786 | null | 113.8 | Not known (9) | 2013-07-27 | 2013-07-29 | Methotrexate intrathecal | N | N | 220033023 | METHOTREXATE INTRATHECAL |
| 220014253 | 220008787 | 0 | 71.6 | Curative (C) | 2015-10-08 | 2015-11-18 | ADE 10+3+5 | 2 | N | 220033026 | ADE |
| 220014254 | 220014717 | 1.61 | 80.9 | Disease modification (D) | 2015-01-24 | 2015-01-30 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220033029 | IDARUBICIN + TRETINOIN |
| 220014255 | 220014717 | 1.71 | null | Palliative (P) | 2015-11-24 | 2015-11-27 | IDARUBICIN + TRETINOIN | N | N | 220033029 | IDARUBICIN + TRETINOIN |
| 220014256 | 220014717 | 1.65 | 81.2 | Palliative (P) | 2017-07-09 | 2017-10-27 | Cyclophosphamide TBI Allograft | N | N | 220033029 | CYCLOPHOSPHAMIDE |
| 220014257 | 220008788 | 1.66 | 75 | Curative (C) | 2017-01-02 | 2017-02-18 | BOSUTINIB | 2 | N | 220033036 | BOSUTINIB |
| 220014258 | 220008789 | 1.68 | 84 | Palliative (P) | 2013-06-16 | 2013-06-18 | FLAG | N | N | 220033039 | FLAG |
| 220014259 | 220014719 | 1.77 | 83.7 | null | 2016-03-22 | 2016-04-30 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220033040 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014260 | 220014719 | 1.57 | 106 | Not known (9) | null | 2014-12-31 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220033040 | IDARUBICIN + TRETINOIN |
| 220014261 | 220019898 | 1.69 | 60.3 | Curative (C) | null | 2015-09-22 | RUXOLITINIB | N | N | 220033041 | RUXOLITINIB |
| 220014262 | 220008792 | 1.63 | 57.4 | Disease modification (D) | 2016-08-15 | 2016-12-08 | BOSUTINIB | N | N | 220033055 | BOSUTINIB |
| 220014263 | 220008793 | 1.57 | 45.6 | Not known (9) | 2013-10-13 | 2013-10-24 | Cyclophosphamide+Fludara+TBI Allo | 2 | Y | 220033060 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014264 | 220008793 | null | null | Palliative (P) | 2017-03-09 | 2017-03-12 | Idarubicin+Tretinoin Spanish Crse1 | null | null | 220033060 | IDARUBICIN + TRETINOIN |
| 220014265 | 220008793 | 1.64 | 71 | Disease modification (D) | 2015-06-15 | 2015-06-26 | AML Int Guide ADE 10+3+5 (1) | 2 | null | 220033060 | ADE |
| 220014266 | 220008795 | 1.86 | 92.6 | Curative (C) | 2013-01-09 | 2014-03-29 | RUXOLITINIB | 02 | N | 220033075 | RUXOLITINIB |
| 220014267 | 220018043 | 1.75 | null | Palliative (P) | 2013-11-10 | 2013-11-17 | Idarubicin+Tretinoin Spanish Crse2 | N | N | 220033078 | IDARUBICIN + TRETINOIN |
| 220014268 | 220018043 | 1.76 | null | Palliative (P) | 2013-09-27 | 2013-09-27 | RUXOLITINIB | 2 | N | 220033078 | RUXOLITINIB |
| 220014269 | 220008796 | 1.65 | 98.4 | Disease modification (D) | null | 2016-03-04 | Triple / Double Intrathecal Therapy | N | null | 220033081 | TRIPLE INTRATHECAL |
| 220014271 | 220008799 | 1.56 | 65 | null | 2014-02-13 | 2014-07-15 | ATG + Busulfan + Fludarabine | Y | N | 220033087 | ATG + BUSULFAN + FLUDARABINE |
| 220014272 | 220008801 | 1.28 | 60 | Curative (C) | 2015-12-10 | 2016-02-10 | RUXOLITINIB | 02 | N | 220033090 | RUXOLITINIB |
| 220014273 | 220008801 | null | null | 3 | 2014-02-22 | 2014-02-26 | AML16 Low Dose Cytarabine | N | N | 220033090 | AML16 TRIAL |
| 220014275 | 220008806 | 1.65 | null | Curative (C) | 2016-06-03 | 2016-09-28 | IDARUBICIN + TRETINOIN | 02 | null | 220033114 | IDARUBICIN + TRETINOIN |
| 220014276 | 220008808 | 1.88 | 85.2 | Curative (C) | 2012-10-28 | 2013-12-02 | FLAG | 02 | N | 220033116 | FLAG |
| 220014277 | 220008810 | 1.55 | 69.4 | Disease modification (D) | 2013-06-03 | 2013-08-03 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220033117 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014278 | 220008812 | 1.61 | 94 | null | 2016-07-12 | 2017-09-23 | RUXOLITINIB | N | N | 220033121 | RUXOLITINIB |
| 220014279 | 220008813 | 1.72 | 81.4 | Palliative (P) | 2016-10-02 | 2016-10-02 | Cyclophosphamide TBI Allograft | 2 | N | 220033122 | CYCLOPHOSPHAMIDE |
| 220014280 | 220008815 | null | null | Disease modification (D) | null | 2016-07-10 | Cyclophosphamide TBI Allograft | N | Y | 220033123 | CYCLOPHOSPHAMIDE |
| 220014281 | 220008816 | null | null | Curative (C) | 2014-06-17 | 2014-06-19 | CYCLOPHOSPHAMIDE | 2 | N | 220033123 | CYCLOPHOSPHAMIDE |
| 220014282 | 220008816 | 1.08 | 20.5 | Curative (C) | null | 2013-08-05 | Cyclophosphamide+Fludara+TBI Allo | null | null | 220033123 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014283 | 220008817 | 1.41 | 55.8 | null | 2017-05-15 | 2017-05-15 | Triple / Double Intrathecal Therapy | N | null | 220033132 | TRIPLE INTRATHECAL |
| 220014284 | 220008819 | 1.9 | 52.2 | Curative (C) | 2014-01-20 | 2014-02-17 | ATG + Busulfan + Fludarabine | 02 | N | 220033133 | ATG + BUSULFAN + FLUDARABINE |
| 220014285 | 220008819 | 1.58 | null | Disease modification (D) | 2017-11-30 | 2017-11-30 | BOSUTINIB | N | N | 220033133 | BOSUTINIB |
| 220014286 | 220008820 | 1.56 | 23.6 | Curative (C) | 2016-01-15 | 2016-02-05 | BOSUTINIB | Y | N | 220033138 | BOSUTINIB |
| 220014287 | 220008821 | null | null | Curative (C) | 2015-06-15 | 2015-09-02 | BOSUTINIB | 2 | N | 220033144 | BOSUTINIB |
| 220014288 | 220008822 | 1.6 | 55 | null | 2014-09-19 | 2014-11-01 | RUXOLITINIB | 02 | null | 220033147 | RUXOLITINIB |
| 220014291 | 220014732 | null | 0 | Disease modification (D) | null | 2017-04-08 | IDARUBICIN + TRETINOIN | 02 | N | 220033151 | IDARUBICIN + TRETINOIN |
| 220014292 | 220008829 | null | 78.8 | Curative (C) | 2016-07-10 | 2016-07-10 | Methotrexate intrathecal | N | N | 220033159 | METHOTREXATE INTRATHECAL |
| 220014293 | 220014733 | 1.3 | 63.9 | null | 2017-11-28 | 2017-12-05 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 220033159 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220014294 | 220014733 | 1.8 | null | Palliative (P) | 2014-07-19 | 2015-10-13 | ATG + Busulfan + Fludarabine | 02 | Y | 220033159 | ATG + BUSULFAN + FLUDARABINE |
| 220014295 | 220008830 | 1.77 | 70.9 | null | 2013-10-05 | 2014-05-03 | Idarubicin+Tretinoin Spanish Crse1 | Y | N | 220033173 | IDARUBICIN + TRETINOIN |
| 220014296 | 220008832 | 1.6 | 64 | Curative (C) | 2018-02-26 | 2018-03-04 | PACLITAXEL | N | N | 220033178 | PACLITAXEL |